SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision

TREM2 agonism vs antagonism in DAM microglia

RESOLVED

The disease-associated microglia (DAM) phenotype involves TREM2 upregulation, but whether therapeutic agonism or antagonism of TREM2 is beneficial remains contested across disease stages.

Priority: 0.92 Domain: neurodegeneration Hypotheses: 24
📊 Landscape Analysis

Landscape Summary: TREM2 agonism vs antagonism in DAM microglia is a 0.92 priority gap in neurodegeneration. It has 24 linked hypotheses with average composite score 0.649. Status: resolved.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

TREM2 agonism vs antagonism in DAM microglia — INVOKE-2 (completed)

📈 Living Dashboards
24
Hypotheses
0.761
Top Score
0.649
Avg Score
0
Debates
0.00
Avg Quality
100%
Resolution
0
Mechanistic Families
Gap Resolution Progress100%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Target: TREM2 Pathway: Microglial Activation / DAM Si
0.761
score
APOE-TREM2 Interaction Modulation
Target: TREM2 Pathway: APOE-TREM2 lipid sensing / mic
0.741
score
Oligodendrocyte Remyelination Enhancement
Target: TREM2 Pathway: TREM2/TYROBP microglial signal
0.644
score
Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in Early Amy
Target: TREM2 Pathway: microglial phagocytosis
0.637
score
TREM2 R47H Variant Correction — AAV-Mediated Rescue of Common Risk All
Target: TREM2 Pathway: lipid sensing, APOE binding
0.631
score
TREM2 Antagonism in Late-Stage Tauopathy — Reducing Neuroinflammatory
Target: TREM2 Pathway: neuroinflammation, tau patholo
0.628
score
Microglial TREM2 downregulation impairs damage-associated response in
Target: TREM2 Pathway: TREM2/TYROBP microglial signal
0.626
score
TREM2-Dependent Microglial Senescence Transition
Target: TREM2 Pathway: TREM2/TYROBP microglial activa
0.618
score
TREM2-mediated microglial tau clearance enhancement
Target: TREM2 Pathway: TREM2-DAP12 microglial signali
0.618
score
TREM2-Mediated Selective Aggregate Clearance Pathway
Target: TREM2 Pathway: TREM2 → SYK → PI3K/mTOR phagoc
0.584
score
🌊 Knowledge Graph Connections

activates (10)

TREM2→AlzheimerTREM2→ALZHEIMER'S DISEASETREM2→NeuroinflammationMICROGLIA→TREM2TREM2→ALZHEIMER
▸ Show 5 more

associated with (14)

TREM2→ALZHEIMER'S DISEASETREM2→MICROGLIAALZHEIMER'S DISEASE→TREM2TREM2→neurodegenerationAMYLOID→TREM2
▸ Show 9 more

data in (8)

ad_genetic_risk_loci:TREM2→TREM2benchmark_ot_ad_answer_key:TREM2→TREM2TREM2→benchmark_ot_ad_answer_key:TREM2ds-db4a006ea647→TREM2ds-f50762b67605→TREM2
▸ Show 3 more

expressed in (3)

TREM2→AlzheimerTREM2→MICROGLIAMICROGLIA→TREM2

inhibits (1)

TREM2→Inflammation

provides data for (5)

TREM2→ds-83b31ef18d49TREM2→ds-6784494f1741TREM2→ds-db4a006ea647TREM2→ds-f50762b67605TREM2→ds-f2c28aed24a7

regulates (2)

TREM2→MICROGLIATREM2→Alzheimer

relates to (2)

h-immunity-c3bc272f→TREM2h-immunity-c64967ab→TREM2

therapeutic target (5)

TREM2→AlzheimerTREM2→NeuroinflammationTREM2→ALZHEIMER'S DISEASETREM2→ALZHEIMERTREM2→Inflammation
🕑 Activity Feed
📈 TREM2 R47H Variant Correction — AAV-Mediated Rescue of Commo score=0.631 2026-04-04T18:09
📈 Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in score=0.637 2026-04-04T18:01
📈 Oligodendrocyte Remyelination Enhancement score=0.644 2026-04-04T13:36
📈 APOE-TREM2 Interaction Modulation score=0.741 2026-04-02T20:53
📈 Cell-Type Specific TREM2 Upregulation in DAM Microglia score=0.761 2026-04-02T19:52
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps